lobbying_activities: 3489979

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3489979	23560269-e700-4b9a-873b-23c76a0203bb	Q4	BROWNSTEIN HYATT FARBER SCHRECK, LLP	7257	PIERRE FABRE PHARMACEUTICALS INC.	2025	fourth_quarter	PHA	Issues related to drug development, rare disease innovations, and issues impacting the pharmaceutical industry.	HOUSE OF REPRESENTATIVES,SENATE	50000		0	0	2026-01-16T14:56:51-05:00